References
- Shankar EM, Kumarasamy N, Bella D, et al. Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS. Can Respir J. 2006 Jul-Aug;13(5):275–278.
- Banerjee P, Haider M, Trehan V, et al. Cryptococcus laurentii fungemia. Indian J Med Microbiol. 2013 Jan-March;31(1):75–77. DOI:10.4103/0255-0857.108731.
- Khawcharoenporn T, Apisarnthanarak A, Mundy LM. Non-neoformans cryptococcal infections: a systematic review. Infection. 2007 Apr;35(2):51–58.
- Arendrup MC, Boekhout T, Akova M, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect. 2014;20(Suppl. 3):76–98.
- Furman-Kuklińska K, Naumnik B, Myśliwiec M. Fungemia due to Cryptococcus laurentii as a complication of immunosuppressive therapy–a case report. Adv Med Sci. 2009;54(1):116–119.
- Molina-Leyva A, Husein-Elahmed H, Ruiz-Carrascosa JC, et al. Cutaneous Cryptococcus laurentii infection in an immunocompetent Child. Int J Infect Dis. 2013;17:e1232–e1233.
- Averbuch D, Boekhout T, Falk R, et al. Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii. Med Mycol. 2002;40(5):479–484.
- Maligie MA, Selitrennikoff CP. Cryptococcus neoformans resistance to echinocandins: (1,3)β-glucan synthase activity is sensitive to echinocandins. Antimicrob Agents Chemother. 2005 Jul;49(7):2851–2856.
- Ajesh K, Sreejith K. Cryptococcus laurentii biofilms: structure, development and antifungal drug resistance. Mycopathologia. 2012 Dec;174(5–6):409–419. Epub 2012 Sep 1. DOI:10.1007/s11046-012-9575-2.
- Johnson LB, Bradley SF, Kauffman CA. Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. Mycoses. 1998;41:277–280.
- Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. IDSA; [ cited 2011 Aug 14]. Available from: cid.oxfordjournals.org